ArticleThe international journal of cardiovascular imaging2026
Myocardial iodine attenuation is associated with coronary artery stenosis severity: insights from photon-counting CT.
Article in The international journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To investigate whether myocardial iodine attenuation and iodine/virtual non-contrast (VNC) ratios derived from photon-counting detector CT (PCCT) are associated with coronary artery stenosis severity as classified by CAD-RADS, and to evaluate their potential complementary value to anatomical grading. In this retrospective single-center study, 57 patients (42.1% women; mean age 64.2 ± 13.0 years) who underwent clinically indicated coronary CT angiography using PCCT were included if they had either no coronary atherosclerosis or a measurable atherosclerotic lesion involving the left main or left anterior descending coronary artery, allowing iodine assessment in the corresponding LAD myocardial territory. Myocardial iodine attenuation was quantified on iodine maps using three circular regions of interest placed in the anterior left ventricular wall on mid-ventricular multiplanar reconstructions. Mean iodine attenuation and iodine/VNC ratios were calculated per patient. Coronary artery disease severity was graded according to CAD-RADS 2.0. Associations were assessed using Spearman correlation and linear regression analyses adjusted for age, body mass index, and VNC attenuation. Mean myocardial iodine attenuation was 32.1 ± 18.5 HU, and the mean iodine/VNC ratio was 0.69 ± 0.52. Both metrics showed an overall decrease with increasing CAD-RADS category, with the lowest values observed in patients with CAD-RADS 4 (iodine attenuation 16.4 ± 12.9 HU; iodine/VNC ratio 0.24 ± 0.15). Significant inverse correlations were observed between CAD-RADS category and iodine attenuation (r = -0.54, p < 0.001) as well as iodine/VNC ratio (r = -0.70, p < 0.001). In multivariable analyses, CAD-RADS category remained independently associated with iodine attenuation (β = -8.61 HU per category increase, p < 0.001) and iodine/VNC ratio (β = -0.14, p = 0.003). Myocardial iodine attenuation and iodine/VNC ratios derived from photon-counting CT are associated with coronary artery stenosis severity, classified by CAD-RADS, and may serve as quantitative adjuncts to anatomical coronary assessment. Further validation against established functional reference standards is required.
Indexed as
Identifiers
42584537What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.